2017 Satellite Symposia at WORLDSymposium

Monday Dinner, February 13, 2017, 6:00 – 8:00 PM
Newborn Screening for Lysosomal Diseases: Recent Progress and Unanswered Questions
CME Satellite Symposium Sponsored by MedIQ
Supported by an educational grant from Sanofi Genzyme

Tuesday Breakfast, February 14, 2017, 6:30 – 7:30 AM
On the Frontline of Managing Patients with Lysosomal Diseases
Supported by Shire Commerical

Tuesday Breakfast, February 14, 2017, 6:30 – 7:30 AM
Accelerating the Conversation
Supported by Pfizer, Inc.

Tuesday Lunch, February 14, 2017, 11:45 AM – 12:45 PM
Altering the course of Maroteaux-Lamy and Morquio A from birth, through adolescence, and beyond
Supported by BioMarin Pharmaceutical Inc.

Tuesday Lunch, February 14, 2017, 11:45 AM – 12:45 PM
MPS II: One Family’s Journey
Supported by Shire Medical

Tuesday Dinner, February 14, 2017, 6:30 – 8:30 PM
Discovery and Research Platforms in Rare Disease
Supported by Shire Medical

Wednesday Breakfast, February 15, 2017, 6:30 – 7:30 AM
MPS II with cognitive impairment: approaches to improving identification and assessment
Supported by Shire Medical

Wednesday Lunch, February 15, 2017, 11:45 AM – 12:45 PM
Precision Medicine in Lysosomal Diseases: Opportunities and Challenges
Supported by Amicus Therapeutics

Wednesday Lunch, February 15, 2017, 11:45 AM – 12:45 PM
Pioneers and Innovators in Gaucher Disease
Supported by Shire Commerical

Wednesday Dinner, February 15, 2017, 6:30 – 8:30 PM
Advances in Fabry Disease: Phenotypic expression, markers of clinical severity and disease progression
Supported by Sanofi Genzyme

Thursday Breakfast, February 16, 2017, 6:30 – 7:30 AM
MPS Skeletal Disease: Current Knowledge
Supported by Ultragenyx Pharmaceutical Inc.

Thursday Breakfast, February 16, 2017, 6:30 – 7:30 AM
Fabry Disease and 15 years of Enzyme Replacement Therapy: Lessons Learned
This satellite is open only to registered attendees from outside the United States. International participants only.
Supported by Sanofi Genzyme

Thursday Lunch, February 16, 2017, 11:45 AM – 12:45 PM
Shifting Diagnosis Earlier in a Time-Critical Disease: The Important Role of Genetics in Finding CLN2
Supported by BioMarin Pharmaceutical Inc.

Thursday Lunch, February 16, 2017, 11:45 AM – 12:45 PM
Accelerating Diagnosis through Panel Testing
Supported by Sanofi Genzyme

Registration for the 13th Annual Scientific Meeting and an official WORLDSymposium name badge were required to attend any of the satellite symposia.

Titles and content for Satellite Symposia were posted as information became available.

These Satellite Symposia were not part of the official WORLDSymposium™ 2017 program, and WORLDSymposium 2017 did not approve or endorse any commercial products or services discussed during these Symposia or offered for sale by the corporate supporter of the Symposium. These Symposia may or may not offer CME credits; these sessions are not approved for CME through WORLDSymposium 2017.